Design, synthesis and biological evaluation of (2S, 3R, 4R, 5S, 6R)-5-fluoro-6-(hydroxymethyl)-2-aryltetrahydro-2H-pyran-3,4-diols as potent and orally active SGLT dual inhibitors

被引:10
|
作者
Xu, Guozhang [1 ]
Gaul, Michael D. [1 ]
Kuo, Gee-Hong [1 ]
Du, Fuyong [1 ]
Xu, June Zhi [1 ]
Wallace, Nathaniel [1 ]
Hinke, Simon [1 ]
Kirchner, Thomas [1 ]
Silva, Jose [1 ]
Huebert, Norman D. [1 ]
Lee, Seunghun [1 ]
Murray, William [1 ]
Liang, Yin [1 ]
Demarest, Keith [1 ]
机构
[1] Janssen Res & Dev LLC, Discovery Sci & Cardiovasc & Metab Res, Welsh & McKean Rd, Spring House, PA 19477 USA
关键词
Diabetes; Glucose transporter; SGLT1; inhibitor; SGLT2; Bioisostere; C-Aryl glucoside; AFFINITY NA+/GLUCOSE COTRANSPORTER; C-GLUCOSIDE; DISCOVERY; TRANSPORT; KIDNEY;
D O I
10.1016/j.bmcl.2018.09.025
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
A new series of (2S, 3R, 4R, 5S, 6R)-5-fluoro-6-(hydroxymethyl)-2-aryltetrahydro-2H-pyran-3,4-diols as dual inhibitors of sodium glucose co-transporter proteins (SGLTs) were disclosed. Two methods were developed to efficiently synthesize C-5-fluoro-lactones 3 and 4, which are key intermediates to the C-5-fluoro-hexose based C-aryl glucosides. Compound 2b demonstrated potent hSGLT1 and hSGLT2 inhibition (IC50 = 43 nM for SGLT1 and IC50 = 9 nM for SGLT2). It showed robust inhibition of blood glucose excursion in oral glucose tolerance test (OGTT) in Sprague Dawley (SD) rats and exerted pronounced antihyperglycemic effects in db/db mice and high-fat diet-fed ZDF rats when dosed orally at 10 mg/kg.
引用
收藏
页码:3446 / 3453
页数:8
相关论文
共 50 条